Showing results (1031-1040 of 1,221) with videos related to

Sort By:
Pageof 123
Natural Product Research|April 19, 2011
Pharmacognostic and acute toxicological evaluation of Scaptotrigona aff. postica propolis extract in pre-clinical assaysM J A M Araújo, N S Mattar, A S Reis, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.
Nature Communications|February 10, 2024
Regression-based Deep-Learning predicts molecular biomarkers from pathology slidesOmar S M El Nahhas, Chiara M L Loeffler, Zunamys I Carrero, et al.
Frontiers in Molecular Biosciences|October 24, 2022
Distinct mRNA and protein interactomes highlight functional differentiation of major eIF4F-like complexes from Trypanosoma bruceiMaria J R Bezerra, Danielle M N Moura, Eden R Freire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell linesDorine A Bax, Nathalie Gaspar, Suzanne E Little, et al.
NPJ Breast Cancer|July 10, 2025
Genomic landscape of breast cancer in elderly patientsPier Selenica, Higinio Dopeso, Matteo Repetto, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2023
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic CharacterizationFatemeh Derakhshan, Arnaud Da Cruz Paula, Pier Selenica, et al.
The Journal of Pathology|January 26, 2016
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutationsElena Guerini-Rocco, Salvatore Piscuoglio, Charlotte K Y Ng, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 9, 2022
Molecular Biomarkers of Disease Outcomes and Mechanisms of Acquired Resistance to First-Line Osimertinib in Advanced EGFR-Mutant Lung CancersNoura J Choudhury, Antonio Marra, Jane S Y Sui, et al.
Pageof 123